KRT16 and breast carcinoma: Breast cancer patients analysis reveals that the loss of acetylated H4 at K16 may serve as an early sign of cancer, and low levels of H3 acetylated at K9 and K14 and H4 at K12 are prognostic of poor outcomes [84].